Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 09:11:02 GMT 2023
by
admin
on
Sat Dec 16 09:11:02 GMT 2023
|
Protein Type | MONOCLONAL ANTIBODY |
Protein Sub Type | IGG1 |
Sequence Origin | MOUSE CHIMERIC |
Sequence Type | COMPLETE |
Record UNII |
29Z5DNL48C
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
224306
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
||
|
NDF-RT |
N0000192703
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
||
|
WHO-ATC |
J06BB22
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/18/2065
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
29Z5DNL48C
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
1746906
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
m11939
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
CHEMBL3544926
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
ZZ-114
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
100000182406
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
8336
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
Obiltoxaximab
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
C166561
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
N0000192702
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | Anthrax Protective Antigen-directed Antibody Interactions [MoA] | ||
|
29Z5DNL48C
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
5094
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
Obiltoxaximab
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
1351337-07-9
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
DB05336
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
9825
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY |
From | To |
---|---|
1_22 | 1_96 |
2_22 | 2_96 |
3_23 | 3_88 |
4_23 | 4_88 |
3_134 | 3_194 |
4_134 | 4_194 |
1_146 | 1_202 |
2_146 | 2_202 |
1_222 | 3_214 |
2_222 | 4_214 |
1_228 | 2_228 |
1_231 | 2_231 |
1_263 | 1_323 |
2_263 | 2_323 |
1_369 | 1_427 |
2_369 | 2_427 |
Glycosylation Link Type | Site |
---|---|
N | 1_299 |
N | 2_299 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Molecular Formula | CHEMICAL |
|
||||
MOL_WEIGHT:SEQUENCE(CALCULATED) | CHEMICAL |
|